Gene expression profiling has revealed that breast cancer is a heterogeneous entity, and four primary molecular subgroups have been proposed: basal-like, luminal A, luminal B and human epidermal growth factor receptor 2 (HER2)-overexpressed[2], [3]. The gene discussed is ERBB2; the disease is breast carcinoma.